Igenica
engages in discovery and development of antibody-based therapeutics for the treatment of cancer... Read moreIgenica
engages in discovery and development of antibody-based therapeutics for the treatment of cancer... Read more
Co-Founder
Robert Schreiber
News
Nov 05, 2017
BioPortfolio
Igenica: Igenica Biotherapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 25102017 Prices from USD $250
May 26, 2017
Pharmaceutical Processing
Igenica: Pierre Fabre Acquires Immunotherapies from Igenica Biotherapeutics
May 25, 2017
The Pharma Letter
Igenica: Pierre Fabre sets sights on bigger I-O business
May 24, 2017
Genetic Engineering & Biotechnology News
Igenica: Pierre Fabre Acquires Igenica Immuno-Oncology Assets
May 23, 2017
Blackbird
Press Release: Igenica : Pierre Fabre Pharmaceuticals Acquires Promising Assets from Igenica Biotherapeutics in the Field of Immuno-Oncology
May 08, 2017
BioPortfolio
Igenica: Igenica Biotherapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 26042017 Prices from USD $250
Apr 15, 2017
BioPortfolio
Igenica: Igenica Biotherapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 20032017 Prices from USD $250
Jan 24, 2017
BioPortfolio
Igenica: Igenica Biotherapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
Oct 29, 2015
PHARAMCEUTICAL TECHNOLOGY
Igenica:
Igenica, MedImmune enter into oncology research agreement
Oct 28, 2015
BUSINESS WIRE
Press Release: Igenica : Igenica Biotherapeutics Enters Into a Strategic Oncology Research Agreement with MedImmune
Igenica Competitors
1
2
3
4
5
6
7
8
9
10